TSO3 Inc. (TOS) Analysts See $-0.03 EPS

February 15, 2018 - By Migdalia James

 TSO3 Inc. (TOS) Analysts See $ 0.03 EPS

Analysts expect TSO3 Inc. (TSE:TOS) to report $-0.03 EPS on March, 20.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.03 EPS. After having $-0.03 EPS previously, TSO3 Inc.’s analysts see 0.00 % EPS growth. The stock increased 3.42% or $0.05 during the last trading session, reaching $1.51. About 77,783 shares traded. TSO3 Inc. (TSE:TOS) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

TSO3 Inc. (TSE:TOS) Ratings Coverage

Among 3 analysts covering TS03 (TSE:TOS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. TS03 had 8 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained TSO3 Inc. (TSE:TOS) on Thursday, June 15 with “Outperform” rating. The rating was initiated by M Partners with “Buy” on Tuesday, July 21. The stock has “Buy” rating by Canaccord Genuity on Wednesday, January 27. The firm has “Buy” rating given on Monday, June 26 by Canaccord Genuity.

TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. The company has market cap of $140.21 million. The company's principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. It currently has negative earnings. It also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes; and STERIZONE CI+ chemical indicator in Canada.

More recent TSO3 Inc. (TSE:TOS) news were published by: Prnewswire.com which released: “TSO3 to Present at the RBC Capital Markets Healthcare Conference” on February 14, 2018. Also Seekingalpha.com published the news titled: “TSO3 Inc.: Taking The Fight To The Superbugs” on September 21, 2017. Prnewswire.com‘s news article titled: “TSO3 creates US entity – Plans to open US facility” with publication date: July 06, 2015 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: